Physician profile
Paban Saha
NPI 1275698144
$19,659.78
in general payments reported to CMS, 2019-2025
23 companies · $5,065 in 2025
The $5,065 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $1,048 · 2021: $3,379 · 2022: $3,742 · 2023: $1,514 · 2024: $3,522 · 2025: $5,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,973 · Consulting Fee: $2,404 · Travel and Lodging: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,973.24 |
| Consulting Fee | $2,403.70 |
| Travel and Lodging | $724.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $6,888.86 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Soundstar |
| Abbott Laboratories | $5,889.42 | 2019-2025 | Ensite, Amplatzer Amulet, Aveir |
| Boston Scientific Corporation | $1,969.99 | 2019-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Medtronic, INC. | $1,865.60 | 2021-2025 | Azure Xt Dr Mri Surescan, Linq II, Micra |
| Medical Device Business Services, INC. | $1,361.50 | 2021-2024 | Carto 3 |
| Medtronic Vascular, INC. | $503.27 | 2019-2020 | |
| Abiomed | $369.41 | 2020-2025 | |
| Shockwave Medical, INC | $296.41 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $92.05 | 2024-2025 | Amvia Edge, Renamic Neo |
| Philips North America LLC | $71.86 | 2024-2025 | Igt Devices Undivided, (Br2) Coronary Thrombectomy, (Am6) Laser Service and Other |
| Edwards Lifesciences Corporation | $62.82 | 2019 | |
| Heartflow, INC. | $43.07 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $38.38 | 2025 | Eliquis, Camzyos |
| Cardiva Medical, INC. | $36.99 | 2021 | |
| Pfizer INC. | $32.45 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $30.14 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.30 | 2020 | |
| Cordis US Corp. | $20.63 | 2025 | Mynx Control Venous |
| Esperion Therapeutics, INC. | $18.37 | 2025 | Nexletol |
| Merck Sharp & Dohme LLC | $18.25 | 2024 | Bridion |
| Cardiovascular Systems INC. | $14.95 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.06 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paban Saha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.